Thomas S. Kupper, MD, BWH Dermatology Chairman, T32 Principal Investigator
Dr. Kupper is the Chair of the Department of Dermatology at Brigham and Women’s Hospital and the Dana Farber Cancer Institute, and the Thomas B Fitzpatrick Professor of Dermatology at Harvard Medical School. He is the Director of the Cutaneous Oncology Disease Center and leads the Cutaneous Lymphoma Program at the Dana-Farber Brigham and Women’s Cancer Center. One of Dr. Kupper’s highest priorities is to preserve and enhance the role of the physician-scientist in modern academic medicine, particularly to study processes relevant to skin disease and skin cancer. He has served as the PI of this T32 grant since 2000.
Executive Committee
David Fisher, MD, PhD, Massachusetts General Hospital
Hans Oegtten, MD, PhD, Boston Children’s Hospital
Individuals interested in fellowship opportunities are encouraged to contact individual faculty and view faculty webpages.
Speakers & Seminars
Upcoming
April 16 th, 2025 | 12:00-12:30pm | “Data Discussions: Let’s Write a DMS Plan”, Julie Goldman, Research Data Services, Harvard Countway Library
June 25th-27th | Skin Inflammation in Human Health & Disease: 2025 International Conference
Past
January 7 th, 2025 | 9:30am-10:30am | “UV-induced prion-like aggregate seeding in melanosomal proteins and chronic pigmentary dysfunction”, Dr. Nicholas Theodasakis, MD, PhD, Mass General Hospital, Harvard Medical School
January 10 th, 2025 | 9:30am-10:30am | “Dermatology in the Era of Immunotherapy”, Dr. Eugene R. Semenov, MD, Mass General Hospital, Harvard Medical School
January 31 st, 2025 | 9:30am-10:30am | “The Power of Post-Transcriptional Gene Regulation in Skin”, Dr. Anna Mandinova, MD, PhD, Mass General Hospital, Harvard Medical School
February 4 th, 2025 | 9:30am-10:30am | “Dermatologic complications of hematopoietic stem cell transplantation in children”, Dr. Jennifer Huang, MD, Boston Children’s Hospital, Harvard Medical School
2024
April 5 th, 2024 | 9:30am -10:30am | “Granzyme K drives a novel pathway of complement activation”, Dr. Erin Theisen, MD, PhD, Brigham and Women’s Hospital, Harvard Medical School
April 8 th, 2024 | 12:00pm – 1:00pm | “Unconventional TCR Recognition”, Professor Jamie Rossjohn, FAA, FAHMS, Monash University
May 3 rd, 2024 | 9:30am-10:30am | “Specific recruitment of type 1 innate lymphoid cells to mature tertiary lymphoid structures in human sarcoidosis”, Dr. Satish Sati, PhD, UMass Chan Medical School
June 21 st, 2024 | 9:30am-10:30am | “Personalized Neoantigen Vaccines: Moving Towards the Clinic”, Dr. Patrick A. Ott, MD, PhD, Dana-Farber Cancer Institute, Harvard Medical School
June 28 th, 2024 | 9:30am-10:30am | “A possible Role for Skin Resident Memory T Cells in Eosinophilic Fasciitis & Morphea”, Dr. William Crisler, PhD, Brigham and Women’s Hospital, Harvard Medical School
August 13 th, 2024 | 12:00pm-1:00pm | “Research manuscript preparation: Citation and note-taking tools to guard against plagiarism”, Scott Lapinski, MS, ALM, Harvard Countway Library
August 7 th, 2024 | 12:00pm-3:00pm | “Symposium: Gene Lay Institute, Immunity and Inflammation in disease and tissue”, Susan Kaech, Salk Institute; Ruslan Medzhitov, Yale School of Medicine; Fiona Powrie, University of Oxford; Aviv Regev, Genentech
September 19 th, 2024 | 12:00pm-1:00pm | “Evidence for Reducing Infections, Hospitalizations, and Antibiotic Resistant Pathogens”, Dr. Susan Huang, MD, MPH, University of California Irvine School of Medicine
October 1 st, 2024 | 12:00pm-4:00pm | “Research Misconduct (RCR Rounds)”, Dr. Paul Anderson, MD, PhD, Brigham and Women’s Hospital, Harvard Medical School
October 18 th, 2024 | 9:30am-10:30am | “Advancing Skin and Immune Mechanisms Through G Protein-coupled Receptors”, Dr. Jeffrey Smith, MD, PhD, Brigham and Women’s Hospital, Harvard Medical School
October 22 nd, 2024 | 9:30am-10:30am | “Lichen Planus: Interferons, Cytotoxic T-Cells and Paradigm Shifts”, Dr. Aaron R. Mangold, MD, Mayo Clinic
November 8 th, 2024 | 9:30am-10:30am | “Location, location, location: spatial gene expression and the rheum-derm intersection”, Dr. Rochelle Castillo, MD, Brigham and Women’s Hospital, Harvard Medical School
December 3 rd, 2024 | 9:30am-10:30am | “Translational Research – Try to Make an Impact”, Dr. R. Rox Anderson, MD, PhD, Wellman Center at Mass General Hospital, Harvard Medical School
2023
April 7 th | 9:30-10:30am| “Metabolic control of T cell dysfunction in cancer”, Greg Delgoffe, PhD, from University of Pittsburgh
July 12 th-14 th | Skin Inflammation in Human Health & Disease: 2023 International Conference
2022
Friday, February 4th | 9:30am-10:30am | “The memory of arthritis in joints”, Margaret Chang, MD, PhD, from Boston Children’s Hospital
Friday, March 4th | 9:30am-10:30am| “Diet, Lipid and Anti-Tumor Immunity”, Lydia Lynch, PhD, from Brigham and Women’s Hospital
Friday, March 11th | 9:30am-10:30am | “Epigenetic and Metabolic Interplay in the Balance Between Epidermal Differentiation and Carcinogenesis”, Brian C. Capell, MD, PhD, from University of Pennsylvania
Thursday, April 7th | 12:30pm-1:30pm | “Unexpected ion channel functions”, Lily jan, PhD, UC from UC San Francisco
Tuesday, May 24th 12:00pm-1:00pm | “Visiting Clerkship Program and Harvard Affiliated Residencies in Dermatology Forum”
Thursday, June 16th 12:30pm-1:30pm | “Functional Modules in Large Transcriptional Co-activator Complexes”, Eva Nogales, PhD, UC Berkeley
Wednesday, August 10th 12:00pm-12:30pm | “I’ve Generated Data, Now What?: The When, Where, and How of Data Storage”
Thursday, September 15th & Friday, September 16th | “HSCI Stem Cells & Cancer in the Skin & Solid Organs Symposium 2022”
Friday, September 23rd | 12:00-1:00pm | “The landscape of tumor infiltrating T cells in melanoma” Cathering J. Wu, MD from Dana-Farber Cancer Institute
Thursday, Sep 29, 2022 | 1:00PM – 2:00PM | Issues Related to Withdrawing Participants from Study Protocols: Case Studies | Gail Adler, MD, PhD
Friday, September 30th | 9:30-10:30am | “Th17 Immunity in acne vulgaris” George Agak, PhD from University of California at Los Angeles
Wednesday, Oct 19, 2022 | 10:00AM – 11:00AM | Misconduct of Research Integrity | Paul Anderson, MD, PhD
Monday, Nov 7, 2022 | 1:00PM – 2:00PM | Tissue Issues: IRB Perspectives | Martha Jones, MA, CIP
Thursday, Dec 8, 2022 | 2:00PM – 3:00PM | Societal Impacts of Clinical Research | Gad Marshall, MD
Trainee Application Process
Eligibility /Qualifications:
· MD, PhD, MD-PhD, or equivalent degree.
· Appointments to this training grant are restricted to US citizens, non-citizen national or permanent residents of the United States per NIH guidelines.
· Two-year training commitment.
· Trainees are required to pursue their research training full time, defined as 40 hours per week to the program and its related research activities.
Dermatology T32 Trainees will receive:
· Annual stipend at the NIH-specified level, based on full years of relevant postdoctoral experience at the time of appointment.
· Tuition limited to that required for specific courses in support of the approved training program.
· Travel funds for a training experience, such as attendance and presentation of research at a national conference.
Fill out the Application form and upload documents here
For Questions or More Information:
The Brigham and Woman’s Hospital
Department of Dermatology
221 Longwood Avenue
Boston, MA 02115
Attn: Tanya Felton
